Dr. Vatsal Patel is a radiation oncologist trained at UT Health SA MD Anderson Cancer Center, Texas. He offers evidencebased, competent, and compassionate curative care as well as palliative care to improve quality of life for his cancer patients.
Dr. Patel received his Bachelor of Science degree (University Scholar; Honors Scholar; Summa Cum Laude; Phi Betta Kappa as a junior) with a major in Molecular and Cell Biology and minors in Physiology and Neurobiology, and Neuroscience, from the University of Connecticut. He went to University of Connecticut to receive his combined MD/MBA degree, following which he completed a year of internship in traditional medicine program at Yale. Thereafter, he completed a year of Diagnostic Radiology at Yale before transferring to Texas to follow his passion for oncology. Dr. Patel completed his Radiation Oncology residency at UT Health SA MD Anderson Cancer Center in Texas. Dr. Patel has authored several publications during the course of his academic career. Following graduation, Dr. Patel practiced as an attending in Sioux City, Iowa, before moving to Modesto, California. In Iowa, Dr. Patel was one of the only two radiation oncologists in the town. Dr. Patel’s passion for a community based practice that can make a difference in the lives of his patients was well-received and acknowledged through excellent patient satisfaction scores, online reviews, and acceptance of his philanthropic contribution for a special landscaping project for the only comprehensive cancer center in Sioux City.
Dr. Patel has a strong interest in global oncology and is actively engaged in providing virtual oncology consultations for a second opinion to patients around the world. He has served patients from India, Pakistan, Bangladesh, Qatar and other Middle eastern/African nations. In his spare time, he enjoys swimming, biking, cooking, traveling, weight-lifting, horseback-riding, acting, film-making, and engagement in local communities.
Expertise And Interests
- Radiation Oncology - specializing in breast cancer; lung cancer; skin cancers; lymphomas and myelomas; head and neck cancers; sarcomas; gastrointestinal malignancies such as rectal cancer, pancreatic cancer, gastric cancer, esophageal cancer; genitourinary malignancies such as bladder cancer, prostate cancer, testicular cancer; gynecologic malignancies such as vulvar, cervical, endometrial cancer; central nervous system tumors; keloid treatment; heterotopic ossification prophylaxis; trigeminal neuralgia.
In the news
Northern California Patients Now Have Access to Noninvasive Varian Edge Cancer Treatment
August 27, 2021View Article